Metastatic Sarcoma Terminated Phase 2 Trials for Atezolizumab (DB11595)
Also known as: Sarcoma metastatic / Metastatic sarcoma (disorder) / Sarcoma, metastatic (morphologic abnormality)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0047219 (Metastatic Sarcoma) | Terminated | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02609984 | Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) | Treatment |